President’s exclusion from the operation in Venezuela an expression of his anti-interventionist ideology—or a political ...
The writer is President Trump’s senior counsellor for trade and manufacturing Mexico’s decision last week to impose tariffs of up to 50 per cent on a wide swath of Chinese and other Asian imports is ...
Markets regulator SEBI on Monday (November 24, 2025) proposed a review of the facility for ‘Basic Services Demat Account’ (BSDA) to improve financial inclusion, suggesting that Zero Coupon Zero ...
LPL Financial has acquired a minority stake in Private Advisor Group, as the independent-broker dealer expands its grip on assets from independent advisors. Private Advisor Group, which manages over ...
JPMorgan Chase & Co. (NYSE:JPM) is one of the best blue-chip stocks to buy now. On November 11, Moody’s upgraded JPMorgan Chase & Co.’s (NYSE:JPM) long-term deposit rating to Aa1 from Aa2. The upgrade ...
Sysco (SYY) is forecasting earnings growth of 10.01% per year, with annual revenue projected to rise by 4.1%. Net profit margins currently stand at 2.2%, down from 2.4% last year. Average annual ...
While much of the wealth-owning world is positively smitten by the financial promise of large language models (LLMs) and the data centers necessary to power them, one major tech investor is sounding ...
In November 2021, the International Olympic Committee (IOC) released the Framework on Fairness, Inclusion and Non-Discrimination on the Basis of Gender Identity and Sex Variations.1 The Framework aims ...
The consideration of Iran’s nuclear program has remained at the centre of our efforts in the past few weeks, especially after the attacks that took place in June. As you will recall, I referred to ...
Michelle Cull is a member of CPA Australia, the Financial Advice Association Australia and President Elect of the Academy of Financial Services in the United States. Michelle is an academic member of ...
NEW YORK--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback